Literature DB >> 7073911

Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.

I A Baker, R Eastham, P C Elwood, M Etherington, J R O'Brien, P M Sweetnam.   

Abstract

In the Speedwell study set up to examine primarily the relation of plasma lipids and ischaemic heart disease in men aged 45 to 64 years drawn randomly from the practices of 16 general practitioners, various haemostatic factors which may contribute both to thrombogenesis and atherogenesis were measured. Fibrinogen measured nephelometrically and plasma viscosity were positively associated with the prevalence of ischaemic heart disease. Antithrombin III was negatively associated with the prevalence of ischaemic heart disease. These associations were statistically significant at the 1% level of probability. Fibrinogen measured by a clotting method and the heparin neutralising activity of platelet poor plasma had negative and positive associations with ischaemic heart disease, respectively, but neither association achieved statistical significance. Because of the interrelation of these variables and also age, a multiple logistic regression analysis was undertaken separately for the two measures of fibrinogen. The negative association of "clottable' fibrinogen and the positive association of plasma viscosity with the prevalence of ischaemic heart disease were confirmed and both were statistically significant at the 5% level of probability. Apart from age the independent association of the other variables with ischaemic heart disease did not achieve statistical significance. Fibrinogen measured by both methods had positive and statistically significant associations with serum total cholesterol, but no associations with serum total triglycerides, smoking, or alcohol consumption. "Clottable' fibrinogen had an inverse and statistically insignificant association with serum high density lipoprotein cholesterol. The observed associations support the concept of the involvement of some haemostatic factors in the aetiology of ischaemic heart disease, and these associations are now being examined more critically in a longitudinal study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073911      PMCID: PMC481167          DOI: 10.1136/hrt.47.5.490

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  22 in total

1.  Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.

Authors:  K Korsan-Bengtsen; L Wilhelmsen; G Tibblin
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  The pathology of acute coronary death.

Authors:  L Jorgensen; J W Haerem; A B Chandler; C F Borchgrevink
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1968

4.  Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis.

Authors:  L O Pilgeram
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

5.  Antithrombin 3 and diseases.

Authors:  E Von Kaulla; K N Von Kaulla
Journal:  Am J Clin Pathol       Date:  1967-07       Impact factor: 2.493

6.  The identification of platelets and platelet antigens in histological sections.

Authors:  K C Carstairs
Journal:  J Pathol Bacteriol       Date:  1965-07

7.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

Review 8.  The viscosity of human blood plasma; its measurement in health and disease.

Authors:  J Harkness
Journal:  Biorheology       Date:  1971-12       Impact factor: 1.875

9.  A new red-sensitive micronephelometer.

Authors:  J M Thorp; G B Horsfall; M C Stone
Journal:  Med Biol Eng       Date:  1967-01

10.  Plasma fibrinogen patterns in patients with coronary atherosclerosis.

Authors:  J W Hampton; J Mantooth; E N Brandt; S G Wolf
Journal:  Circulation       Date:  1966-12       Impact factor: 29.690

View more
  14 in total

1.  Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Authors:  A Mormile; M Veglio; G Gruden; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.

Authors:  J W Yarnell; P M Sweetnam; S Rogers; P C Elwood; D Bainton; I A Baker; R Eastham; J R O'Brien; M D Etherington
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

3.  Haemostatic function in myocardial infarction.

Authors:  A Hamsten; M Blombäck; B Wiman; J Svensson; A Szamosi; U de Faire; L Mettinger
Journal:  Br Heart J       Date:  1986-01

4.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1984-09       Impact factor: 3.710

5.  Haemostatic factors and ischaemic heart disease. The Caerphilly study.

Authors:  J W Yarnell; P M Sweetnam; P C Elwood; R Eastham; R A Gilmour; J R O'Brien; M D Etherington
Journal:  Br Heart J       Date:  1985-05

6.  Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.

Authors:  J W Yarnell; A M Fehily; J Milbank; A J Kubicki; R Eastham; T M Hayes
Journal:  J Epidemiol Community Health       Date:  1983-06       Impact factor: 3.710

7.  High effort, low reward, and cardiovascular risk factors in employed Swedish men and women: baseline results from the WOLF Study.

Authors:  R Peter; L Alfredsson; N Hammar; J Siegrist; T Theorell; P Westerholm
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

8.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

9.  Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria.

Authors:  M Veglio; G Gruden; A Mormile; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

10.  Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study.

Authors:  Y Friedlander; Y Elkana; R Sinnreich; J D Kark
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.